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With an increased level of awareness of sleep disorders among the public, there has been an increase in
requests for sleep studies, and consequently, more referrals made to sleep specialists by primary care
physicians and other health care providers. Understanding technical and clinical information provided in the
sleep study report is crucial. It offers significant insight in to sleep pathophysiology in relation to patient
symptoms. The purpose of this article is to provide a simple and easy method to interpret the reported results
of polysomnography for primary care physicians. This will facilitate better understanding and management of
patients with sleep disorders and related complications.
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P
olysomnography (PSG), popularly known as a
‘sleep study’, has been used for decades to diagnose
and evaluate the severity of sleep-disordered
breathing. There is a significant increase in the demand
for sleep-related evaluations and sleep studies, due to the
heightened public awareness of sleep disorders. Sleep-
disordered breathing is a common public health problem
that affects an estimated 10% of 30- to 49-year-old men;
17% of 50- to 70-year-old men; 3% of 30- to 49-year-old
women; and 9% of 50- to 70-year-old women (1). The
potential life-threatening cardiovascular (2), neurocogni-
tive, and metabolic complications (3) related to untreated
sleep-disordered breathing have intensified the need for
making an early diagnosis. An increasing number of
referrals are made to the sleep specialists by primary
providers after initial history, assessment of sleep hygiene,
and screening with an Epworth Sleepiness Scale (ESS).
The ESS provides a validated measure of the patient’s
general level of daytime sleepiness and provides the
physician with an initial screening tool to help assess
the sleep debt. The patient self-rates the chances that they
would fall asleep while in eight different situations
commonly encountered in daily life. The total ESS score
is based on a scale of 0 to 24, with a score equal to
and above 16 considered to be very sleepy and warrants
further investigation. Total ESS score along with correla-
tions from PSG testing are highly useful in diagnosing
sleep disorders. In patients with obstructive sleep apnea,
ESS scores significantly correlate with an increased
respiratory disturbance index (4).
A review of the lifestyle practices that contribute to
good quality sleep, also called sleep hygiene, is important
before scheduling a sleep study. A discussion with the
patient about a healthy diet, caffeine (and less obvious
sources of caffeine such as chocolate, pain relievers with
caffeine, and herbal supplements) and nicotine restriction
6 hours before bedtime, adequate exercise, maintaining a
darkened and quiet environment suitable for sleeping,
coping strategies with shift work, avoiding napping, and
having a consistent bed time can be valuable in giving the
patient a starting point in sleep improvement. If a
patient’s concern is more that of insomnia, an assessment
with Insomnia Severity Index (5) may be useful. An
assessment of comorbid conditions (i.e., emotional dis-
orders, gastrointestinal disturbances, musculoskeletal
pain, Restless Leg syndrome) and review of medications
that contribute to insomnia (i.e., oxycodone, codeine,
methylphenidate, ephedrine, pseudoephedrine, pheny-
lephrine, amphetamines, albuterol, theophylline, beta
blockers, alpha receptor antagonists, SSRIs, venlafaxine,
and duloxitine) is invaluable (6). A discussion about the
use of alcohol before sleep is important. Although
alcohol shortens sleep latency, it can lead to multiple
awakenings throughout the sleep cycle (sleep fragmenta-
tion). Several contributors to daytime sleepiness may
exist concomitantly and may need further evaluation.
Once the sleep study is completed, the sleep study
report is sent to the referring physician with a recom-
mendation for treatment. Currently, there is no standar-
dization of the reporting process; reports are based on
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regarding the patient’s sleep and its deviation from the
normal. The primary physician’s understanding of these
results is instrumental in clinical decision making and
continuous management of the patients. The intention of
this article is to provide a simple and easy method to
interpret reported results of the PSG.
Components of a sleep study report
Thesleepstudyreportsaretypicallyarrangedintosections
containingpatientinformation,whichincludestheirsleep-
related symptoms, the technical details, quantitative data
regarding distribution of different stages of sleep called
sleep architecture and sleep staging. The technical details
document the number of electroencephalographic (EEG),
electro-oculogram, chin and leg electromyogram, electro-
cardiogram, and air flowat the nose andmouth. The chest
and abdominal wall movements are recorded by plethys-
mographic strain belts. The oxygen saturation is sampled
bycontinuous pulse oximetryandthesnoring microphone
is used for recording the snoring and its intensity. Multiple
simultaneous parameters are recorded using an arrange-
ment of wires and belts called a Montage. The indications
for the study are recorded in the context of patient
complaints, history, medical, psychosocial, and sleep-
related problems as well as their medications. Each of
these elements has a significant impact on the recording of
the data and the interpretation of the sleep study.
Definitions
The next section of the report generally includes sleep
architecture; including total recording time and/or time in
bed along with total sleep time. The total recording time is
the total amount of time during which the patient is in bed
with recording equipment activated. The amount of time
actuallyspentinbedisanimportantlimitingfactorforthe
totalsleeptimeandsleepstages.Apatientwhospendsonly
three to four hours in bed cannot reasonably accumulate
normal amounts of sleep and may not go to all normal
stagesandcyclesofsleep.Therefore,alowtotaltimeinbed
maybeofclinicalsignificanceandmaysupportadiagnosis
of insufficient sleep.
Sleep latency is perhaps one of the most important
parameters in a sleep study. The duration of time between
when the lights are turned off (lights out) as the patient
attempts to sleep, until the time patient actually falls
asleep, as evidenced by EEG and behavioral parameters
changes consistent with sleep, is reported as sleep latency.
Sleep latency is the time in minutes from ‘lights out’ that
marksthestartingoftotalrecordingtimetothefirstepoch
scored as sleep. Sleep latency also indicates if reasonable
attention was paid to the patient’s sleep diary and the
‘lights out’ time was close to the patient’s routine bedtime
athome.Clearly,ifthelightsareturnedoutearlierthanthe
patient’s usual bedtime, sleep latency would be spuriously
long,andthe patient may notfall asleep untilhis/her usual
sleep time is reached. Similarly, if the ‘lights out’ time is
later than the patient’s usual bedtime, the patient will be
sleepy and a spuriously short sleep latency will be re-
corded. It is of utmost importance that the patient’s usual
habitual sleep time is incorporated into the patient’s sleep
study design and ‘lights out’ time is approximated.
The total sleep time is the total amount of sleep time
scored during the total recording time. This includes time
from sleep onset to sleep offset and is distributed through-
out the sleep time as minutes of Stage N1 sleep, Stage N2
sleep,StageN3,andrapideye movement (REM)sleep.All
these times aredescribed in minutes. A low total sleep time
mayindicatethatthepatientsleptforaninsufficientperiod
oftimeduetonon-medical/non-physiologicalreasons,cer-
tainmedicalorsleepdisorders,orasaresultoftheeffectof
medications. Long total sleep time may suggest prior sleep
deprivation, medical conditions, or effects of medications.
High levels of sleep fragmentation, as defined by recurrent
awakenings and/or stage shifts may result in complaints
of non-restorative sleep even when an apparently normal
total sleep time is present.
Sleep efficiency is another important parameter that
refers to percentage of total time in bed actually spent in
sleep. It is calculated as sum of Stage N1, Stage N2, Stage
N3, and REM sleep, divided by the total time in bed and
multiplied by 100. Sleep efficiencygives an overall sense of
how well the patient slept, but it does not distinguish
frequent, brief episodes of wakefulness. A low sleep effi-
ciency percentage could result from long sleep latency and
long sleep offset to lights on time with otherwise normal
quantity and quality of sleep in between. Many labora-
tories report total wake time, that is, the amount of wake
time during the total recording time in minutes after the
sleep onset. The total amount gives a general estimation
foroverallqualityofsleep.Totalwaketimeisthereciprocal
oftotalsleeptime.Ahightotalsleeptimepercentisalways
associatedwithlow totalwake time percent andviceversa.
An important reported parameter is wake after sleep
onset, also known as ‘WASO’. This refers to periods of
wakefulness occurring after defined sleep onset. This
parameter measures wakefulness, excluding the wakeful-
ness occurring before sleep onset. WASO time is a better
reflection of sleep fragmentation.
Wake time after sleep offset is known as ‘WASF’ and
refers to wakefulness that occurs after sleep offset. Long
periods of wakefulness following an atypically early
morning awakening could be consistent with one of the
classic diagnostic signs of depression. This can be found in
elderly patientswhohavenodifficulty infallingasleep,but
wakeupafterthreetofourhoursofsleepandareunableto
return to sleep. This pattern may be seen in patients who
suffer with depression or anxiety and possibly an effect of
medications.
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ment latency also known as REM latency. Rapid eye
movement latency is the time from the sleep onset to the
first epoch of REM sleep; therefore, it depends on the
patient’s sleep latency. The REM sleep cycles every 90 to
120 min intervals throughout the night. The changes in
REM sleep latency are considered potential biological
markers for a number of sleep-related disorders. REM
sleep is very sensitive to the effects of medication, sleep
deprivation, and circadian rhythm disorders. The knowl-
edge of patients’ current medications and the quality of
sleepthenightbeforethesleepstudytherefore,isextremely
importantto review. A short REM latency time may result
fromwithdrawalfromtricyclicanti-depressants(TCAs)or
Monoamine Oxidase Inhibitor (MAOI) medications.
Withdrawal from amphetamines, barbiturates, and alco-
hol can also cause a shortened REM latency period.
Patients with a history of narcolepsy, sleep apnea, and
depression may also have short REM latency. Similarly,
longREMlatencymayresultfromuseofREM-suppressing
medications, including TCAs, MAOIs, amphetamine, bar-
biturates, and alcohol. Sleep apnea and periodic limb
movement of sleep can also lead to long REM sleep
latency.
Stages of sleep
A sleep study report describes the percentages of various
sleep stages. The normal percentage of each stage is
reported with the number of total REM Stage sleep cycles
recorded overnight. In adults, approximately 5% of the
total sleep time is Stage N1; 50% Stage N2; and 20% is
Stage N3 sleep. The remaining 25% is REM stage sleep
(7, 8).
Non-rapid eye movement sleep
Sleep staging is described in a separate section of the
report. Stage N1 sleep is associated with the transition
from wakefulness to sleep and is considered a direct
measure of daytime alertness and the subjective refreshing
qualityof sleep. The quantityand the percentage Stage N1
sleep is an estimate of the degree of sleep fragmentation. A
high percentage of the Stage N1 sleep is generally a result
of frequent arousals caused by sleep disorders, like sleep
apnea, periodic movement of sleep, or snoring. Other
causes of sleep disruption, including environmental dis-
turbances, may also lead to increased amount of Stage N1
sleep.
Stage N2 sleep predominates the sleep stages with 50%
of the total sleep time. It follows the Stage N1 sleep and
continues to recur throughout the night. A low percentage
of Stage N2 sleep may be a result of sleep fragmentation,
increased REM, Stage N3 or a result of obstructive sleep
apnea-related arousals. An increased amount of Stage N2
sleep may also be noted in age-related changes in sleeping
pattern and may be a result of medication effect.
Stage N3 is considered as ‘deep sleep’. It is sometimes
referred as slow wave sleep. The Stage N3 sleep generally
cycles frequently in the first third of the night and begins
to reduce towards the second half of the night. A high
amount of Stage N3 sleep is noted during rebound sleep
(such as recovery sleep after sleep deprivation, initiation
of nocturnal CPAP treatment, or treatment of periodic
limb movement syndrome). Less Stage N3 sleep is noted
as a side effect of certain medications, including benzo-
diazepines, TCAs, and barbiturates. Episodes of night
terror sleep walking, sleep talking, and confusion arou-
sals also occur during Stage N3 sleep (9). Stage N3 is also
known to suppress the occurrence of sleep-disordered
breathing (10).
Rapid-eye movement sleep
The exact function of the REM is uncertain. However, it
occupies approximately 25% of the total sleep time. REM
sleepcyclesoccurevery90to120minthroughoutthenight
withprogressivelyincreasingperiodsoftime.REMsleepis
associatedwithmorefrequentandlongerdurationapneas,
hypopneas, and severe hypoxemia. REM sleep suppresses
periodic leg movements of sleep (11). Certain medications
suppress the REM sleep including amphetamines, barbi-
turates, TCAs, MAOIs, anticholinergics, and alcohol.
Certain sleep disorders, including sleep apnea, REM
behavior sleep disorder, and nightmares occur in REM
sleep. A higher amount of REM sleep is notable during
recovery sleep after selective deprivation of REM sleep.
REM sleep ‘rebound’ occurs after discontinuation of
REM sleep suppressing medications, alcohol, and initia-
tion of CPAP therapy.
Practice implications
An overall review of the sleep study report provides an
excellentaccountofwhatwasrecordedover6to8hoursof
sleep. It is important for the referring physician to review
the sleep study report and correlate patient’s presenting
sleep complaints to the results. Patients may also report
their posttreatment residual problems and complications
to their health care provider. Multiple recommendations
can be made based on the observations made in the sleep
studyreport.Theclinicalmanagementdecisionsregarding
normalizing the long sleep latency may be made by
practicing good sleep hygiene, thus avoiding over the
counter sleep aids and prescription hypnotics. Improve-
ment in sleep efficiency can be accomplishedwith increase
in total sleep time in relation to total time in bed, aswell as
exploring potential causes of poor sleep efficiency. A good
example of this is when adequate pain management is
applied in chronic pain syndrome, resulting in improved
sleep quality.
An understanding of the effect of medications on sleep
architecture and staging helps the primary care physician
manage sleep disorders, as well as the primary disorder
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In general, REM sleep is suppressed by MAO inhibitors
and tricyclide antidepressant, amphetamines, barbitu-
rates, and alcohol. Withdrawals from these medications
cause rebound and excessive REM sleep. Benzodiaze-
pines increase the amount of Stage N2 sleep and reduce
Stage N3 sleep.
Sleep reports are concluded with recommendations
regarding the management plan including the use of
CPAP therapy, consideration of other treatment modali-
ties like oral appliances, and surgical intervention. If
the patient is a candidate for CPAP, management plans
include recommendations for the type and the size of the
mask and whether a warm or cold humidifier is recom-
mended for patient comfort and to prevent drying of
secretions. ‘Ramp time’, a gradual increase in CPAP pres-
sureover many minutes as the patient tries to fall asleep, is
recommended for patients who may not tolerate high
CPAP pressures. If a mouth air leak is notedwhile using a
nasal mask, a chinstrap is recommended to keep the jaw
from falling open.
Multiple variables affect the sleep pattern including the
‘first-night effect’ when the patient cannot sleep well in
the sleep laboratory and has a different sleeping pattern
than usual (12). First-night effect can increase both Stage
N1 sleep and REM latency recorded in the sleep study.
The ‘reverse first-night effect’ is when the patient sleeps
better in the sleep laboratory compared to their home, as
in case of psycho-physiologic insomnia and frequently
observed ‘night to night variability’ in sleep (13). It is
therefore important to realize that in a patient with high
pre-test probability of sleep-disordered breathing, a nega-
tive sleep study may not rule out the condition (14).
A clear understanding of the sleep study report facili-
tates appropriate patient follow up. It enables the phy-
sician to recognize the need for arranging an appointment
with a sleep specialist for the patient to address any
equipment-related trouble-shooting, or to address any
non-compliance issues. Identifying and addressing these
issues early facilitates appropriate treatment and manage-
ment, leading to an improvement in the patient’s feeling of
overall well-being, and potentially to reduce the many
complications associated with sleep-disordered breathing.
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